GN

Gopal Newatia

Active Director Director DIN 00228121
DIN 00228121 First appointment Oct 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2014
Shareholding value •••• Premium profile

About Gopal Newatia

Data last updated:

Gopal Newatia is a Director at Panbross Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Panbross Pharmaceuticals Private Limited reported revenue of ₹1.8 Lakh (FY 2019).

DIN 00228121
Primary Designation Director
Industry Pharma
First Appointment 31 Oct 2014
Oldest Company Age 38 yrs
Largest company Panbross Pharmaceuticals Private Limited · ₹1.8 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Oct 20141988₹1.8 Lakh (FY 2019)Active

Board colleagues of Gopal Newatia

Directorship timeline

Open interactive timeline →
Panbross Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gopal Newatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopal Newatia

Gopal Newatia currently holds 1 directorship: Panbross Pharmaceuticals Private Limited (Director, since 31 Oct 2014, revenue ₹1.8 Lakh (FY 2019)).

Gopal Newatia was first appointed on 31 Oct 2014 as Director at Panbross Pharmaceuticals Private Limited.

The current boards of Gopal Newatia's companies include Ashawani Kumar Newatia (Panbross Pharmaceuticals Private Limited), Bimla Devi Newatia (Panbross Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available